» Articles » PMID: 30360608

Clinical, Epidemiological and Histopathological Aspects in Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation

Overview
Specialty Oncology
Date 2018 Oct 27
PMID 30360608
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Hepatocellular Carcinoma (HCC) is the primary liver cancer with high incidence and mortality rates. Currently one of the major etiologies for liver disease, HCC and liver transplantation is nonalcoholic fatty liver disease (NAFLD). The aim of the present study was to evaluate the epidemiological, histopathological and clinical aspects of HCC transplant patients, with emphasis on NAFLD etiology. Methods: This study included all HCC patients submitted to liver transplantation from 2010 to 2016 of the University Reference Center. The analyzed variables were age, gender, ethnicity, causes that led to liver transplantation, alpha-fetoprotein (AFP) dosage, histological aspects, recurrence, survival and NAFLD. Results: A total of 60 patients were included in the study being 80% men with a mean age of 58.3 ± 10.6 years. All patients were cirrhotic. The causes that led to the transplantation were the presence of the hepatitis C virus (HCV) (56.6% of the patients), an association of the virus with alcohol (20%), the presence of the hepatitis B virus (HBV) (20%), alcoholic liver disease (ALD) (50.9%) and NAFLD (25%). Of the latter, eight were diagnosed pre-transplantation and seven were NAFLD carriers without a previous diagnosis. Regarding the Edmondson-Steiner histological classification, 58.5% of the patients were classified as grade ≤ II. Conclusions: There is predominance of male patients with a mean age of 58.3 years. Degree ≤ II is the most frequent to the Edmondson-Steiner histological classification in the evaluated casuistic. HCV, ALD and NAFLD is the most common etiological agents found in the study. The (high) underestimated prevalence of NAFLD in the pre-transplanted patients is due to the fact that all patients presented cirrhosis, masking NAFLD signals.

Citing Articles

Time trends and geographic distribution of hepatocellular carcinoma in Brazil: An ecological study.

Balbi E, Moreira J, Luiz R, Perez R, de Souza H Medicine (Baltimore). 2022; 101(38):e30614.

PMID: 36197232 PMC: 9509041. DOI: 10.1097/MD.0000000000030614.


Identification of a DNA Damage Response and Repair-Related Gene-Pair Signature for Prognosis Stratification Analysis in Hepatocellular Carcinoma.

Chen Y, Huang M, Zhu J, Xu L, Cheng W, Lu X Front Pharmacol. 2022; 13:857060.

PMID: 35496321 PMC: 9038539. DOI: 10.3389/fphar.2022.857060.


Scirrhous Hepatocellular Carcinoma: Systematic Review and Pooled Data Analysis of Clinical, Radiological, and Histopathological Features.

Murtha-Lemekhova A, Fuchs J, Schulz E, Sterkenburg A, Mayer P, Pfeiffenberger J J Hepatocell Carcinoma. 2021; 8:1269-1279.

PMID: 34712626 PMC: 8547765. DOI: 10.2147/JHC.S328198.


Identification and Validation of Key Genes in Hepatocellular Carcinoma by Bioinformatics Analysis.

Wang J, Peng R, Zhang Z, Zhang Y, Dai Y, Sun Y Biomed Res Int. 2021; 2021:6662114.

PMID: 33688500 PMC: 7925030. DOI: 10.1155/2021/6662114.


Identification of the DNA Replication Regulator MCM Complex Expression and Prognostic Significance in Hepatic Carcinoma.

Cao T, Yi S, Wang L, Zhao J, Xiao J, Xie N Biomed Res Int. 2020; 2020:3574261.

PMID: 32964028 PMC: 7499325. DOI: 10.1155/2020/3574261.


References
1.
Tamura S, Kato T, Berho M, Misiakos E, OBrien C, Reddy K . Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation. Arch Surg. 2001; 136(1):25-30; discussion 31. View

2.
Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, Carucci P . Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology. 2002; 123(1):134-40. DOI: 10.1053/gast.2002.34168. View

3.
EDMONDSON H, STEINER P . Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer. 1954; 7(3):462-503. DOI: 10.1002/1097-0142(195405)7:3<462::aid-cncr2820070308>3.0.co;2-e. View

4.
Cillo U, Vitale A, Bassanello M, Boccagni P, Brolese A, Zanus G . Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma. Ann Surg. 2004; 239(2):150-9. PMC: 1356206. DOI: 10.1097/01.sla.0000109146.72827.76. View

5.
Fattovich G, Stroffolini T, Zagni I, Donato F . Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology. 2004; 127(5 Suppl 1):S35-50. DOI: 10.1053/j.gastro.2004.09.014. View